The realities of biodefense vaccines against Rickettsia

Vaccine

Volumn 27, Issue SUPPL. 4, 2009, Pages

  Walker, David H ^a  

^a UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

Author keywords

Biodefense; Rickettsia; Vaccines; Weapons

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; BETA LACTAM ANTIBIOTIC; CHLORAMPHENICOL; INACTIVATED VACCINE; LIVE VACCINE; RICKETTSIA VACCINE; TETRACYCLINE;

AEROSOL; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL VIRULENCE; BIOLOGICAL WARFARE; DRUG DELIVERY SYSTEM; DRUG MANUFACTURE; DRUG SAFETY; HUMAN; IMMUNIZATION; INFECTION PREVENTION; INNATE IMMUNITY; NONHUMAN; PRIORITY JOURNAL; RICKETTSIA; RICKETTSIACEAE INFECTION; ROCKY MOUNTAIN SPOTTED FEVER;

EID: 77956870713     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2009.07.045     Document Type: Article

References (50)

1. Yu XJ, Walker DH. Family l. Rickettsiaceae. In: Brenner DJ, Kreig NR, Staley JT, editors. Bergey's Manual of Systematic Bacteriology, vol. 2, 2nd ed. New York: Springer Science+Business Media, Inc.; 2005. p. 96-116.
2. Walker DH, Yu X-J. Progress in rickettsial genome analysis from pioneering of Rickettsia prowazekii to the recent Rickettsia typhi. Ann NY Acad Sci 2005;1063:13-25.
3. Alibek K. Biohazard. NewYork: Random House; 1999. p. 3-313.
4. Harris S. Japanese biologicalwarfare research on humans: a case study of microbiology and ethics. Ann NY Acad Sci 1992;666:21-49.
5. Walker DH. Principles of the malicious use of infectious agents to create terror: reasons for concern for organisms of the genus Rickettsia. Ann NY Acad Sci 2003;990:739-42.
6. Kenyon RH, Kishimoto RA, Hall WC. Exposure of guinea pigs to Rickettsia rickettsii by aerosol, nasal, conjunctival, gastric, and subcutaneous routes and protection afforded by an experimental vaccine. Infect Immun 1979;25:580-2.
7. Saslaw S, Carlisle HN. Aerosol infection of monkeys with Rickettsia rickettsii. Bacteriol Rev 1966;30(3):636-44.
8. PikeRM. Laboratory-associated infections:summary and analysis of 3921 cases. Health Lab Sci 1976;13(2):105-14.
9. Eremeeva ME, Dasch GA, Silverman DJ. Quantitative analyses of variations in the injury of endothelial cells elicited by 11 isolates of Rickettsia rickettsii. Clin Diagn Lab Immunol 2001;8(4):788-95.
10. Walker DH. Rickettsiae and rickettsial infections: the current state of knowledge. Clin Infect Dis 2007;45S:39-44.
11. Weiss E, Dressler HR. Increased resistance to chloramphenicol in Rickettsia prowazekii with a note on failure to demonstrate genetic interaction among strains. J Bacteriol 1962;83:409-14.
12. Spencer RR, Parker RR. Rocky Mountain spotted fever: vaccination of monkeys and man. Public Health Rep 1925;40:2159-67.
13. DuPont HL, Hornick RB, Dawkins AT, Heiner GG, Fabrikant IB, Wisseman Jr CL, et al. Rocky Mountain spotted fever: a comparative study of the active immunity induced by inactivated and viable pathogenic Rickettsia rickettsii. J Infect Dis 1973;128:340-4.
14. Kenyon RH, Sammons LSC, Pedersen Jr CE. Comparison of three RockyMountain spotted fever vaccines. J Clin Microbiol 1975;2(4):300-4.
15. Clements ML, Wisseman Jr CL, Woodward TE, Fiset P, Dumler JS, McNamee W, et al. Reactogenicity, immunogenicity, and efficacy of a chick embryo cell-derived vaccine for Rocky Mountain spotted fever. J Infect Dis 1983;148: 922-30.
16. Mason RA, Seligmann EB, Ginn RK. A reference, inactivated, epidemic typhus vaccine: laboratory evaluation of candidate vaccines. J Biol Stand 1976;4:209-16.
17. Anacker RL, List RH, Mann RE, Hayes SF, Thomas LA. Characterization of monoclonal antibodies protecting mice against Rickettsia rickettsii. J Infect Dis 1985;151(6):1052-60.
18. Li H, Lenz B, Walker DH. Protective monoclonal antibodies recognize heat-labile epitopes on surface proteins of spotted fever group rickettsiae. Infect Immun 1988;56:2587-93.
19. Feng H-M, Olano JP, Whitworth T, Popov VL, Walker DH. Fc-dependent polyclonal antibodies and antibodies to outermembrane proteins Aand B, but not to lipopolysaccharide, protect SCID mice against fatal Rickettsia conorii infection. Infect Immun 2004;72(4):2222-8.
20. Feng H-M, Walker DH, Wang JG. Analysis of T-cell-dependent and -independent antigens of Rickettsia conorii with monoclonal antibodies. Infect Immun 1987;55(1):7-15.
21. Wisseman Jr CL. Concepts of louse-borne typhus control in developing countries: the use of the living attenuated E strain typhus vaccine in epidemic and endemic situations. In: Kohn A, Klingberg MA, editors. Immunity in viral and rickettsial diseases. New York: Plenum Publishing Corporation; 1972. p. 97-130.
22. Fox JP, Jordan ME, Gelfand HM. Immunization of man against epidemic typhus by infection with avirulent Rickettsia prowazeki strain E. J Immunol 1957;79:348-54.
23. Balayeva NM, Nikolskaya VN. Enhanced virulence of the vaccine strain E of Rickettsia prowazeki on passaging in white mice and guinea pigs. Acta Virol 1972;16:80-2.
24. Zhang J-Z, Hao J-F, Walker DH, Yu XJ. A mutation inactivating the methyltransferase gene in avirulent Madrid E strain Rickettsia prowazeki reverted to wild type in the virulent revertant strain Evir. Vaccine 2006;24: 2317-23.
25. ChingWM, Wang H, Davis J, DaschGA. Amino acid analysis and multiplemethylation of lysine residues in the surface protein antigen of Rickettsia prowazekii. In: Angeletti RH, editor. Techniques in protein chemistry IV. San Diego: Academic Press, Inc.; 1993. p. 307-14.
26. Walker DH, Ismail N. Emerging and re-emerging rickettsioses: endothelial cell infection and early disease events. Nat Rev Microbiol 2008;6:375-86.
27. Billings AN, Feng H-M, Olano JP, Walker DH. Rickettsial infection in murinemodels activates an early anti-rickettsial effect mediated by NK cells and associated with production of gamma interferon. Am J Trop Med Hyg 2001;65(1):52-6.
28. Clifton DR, Rydkina E, Huyck H, Pryhuber G, Freeman RS, Silverman DJ, et al. Expression and secretion of chemotactic cytokines IL-8 and MCP-1 by human endothelial cells after Rickettsia rickettsii infection: regulation by nuclear transcription factor NF-κB. Int J Med Microbiol 2005;295:267-78.
29. Dignat-George F, Teysseire N, Mutin M, Bardin N, Lesaule G, Raoult D, et al. Rickettsia conorii infection enhances vascular cell adhesion molecule-1-and intercellular adhesion molecule-1-dependent mononuclear cell adherence to endothelial cells. J Infect Dis 1997;175:1142-52.
30. Fang R, Ismail N, Soong L, Popov VL, Whitworth T, Bouyer DH, et al. Differential interaction of dendritic cells with Rickettsia conorii: impact on host susceptibility to murine spotted fever rickettsiosis. Infect Immun 2007;75(6):3112-23.
31. Jordan JM, Woods ME, Soong L, Walker DH. Rickettsiae stimulate dendritic cells through TLR4, leading to enhanced NK cell activation in vivo. J Infect Dis 2009;199:236-42.
32. Jordan JM, Woods ME, Feng H-M, Soong L, Walker DH. Rickettsiae-stimulated dendritic cells mediate protection against lethal rickettsial challenge in an animal model of spotted fever rickettsiosis. J Infect Dis 2007;196:629-38.
33. Jordan JM, Woods ME, Olano JP, Walker DH. Absence of TLR4 signaling in C3H/HeJ mice predisposes to overwhelming rickettsial infection and decreased protective Th1 responses. Infect Immun 2008;76(8):3717-24.
34. Kaplanski G, Teysseire N, Farnarier C, Kaplanski S, Lissitzky JC, Durand JM, et al. IL-6 and IL-8 production from cultured human endothelial cells stimulated by infection with Rickettsia conorii via a cell-associated IL-1α-dependent pathway. J Clin Invest 1995;96:2839-44.
35. Sporn LA, Marder VJ. Interleukin-1αproduction during Rickettsia rickettsii infection of cultured endothelial cells: potential role in autocrine cell stimulation. Infect Immun 1996;64:1609-13.
36. Feng H-M, Walker DH. Mechanisms of intracellular killing of Rickettsia conorii in infected human endothelial cells, hepatocytes, and macrophages. Infect Immun 2000;68(12):6729-36.
37. Feng H-M, Popov VL, Walker DH. Depletion of gamma interferon and tumor necrosis factor alpha in mice with Rickettsia conorii-infected endothelium: impairment of rickettsicidal nitric oxide production resulting in fatal, overwhelming rickettsial disease. Infect Immun 1994;62:1952-60.
38. de Sousa R, Ismail N, Nobrega SD, Franca A, AmaroM, Anes M, et al. Intralesional expression of mRNA of interferon-y, tumor necrosis factor-α, interleukin-10, nitric oxide synthase, indoleamine-2, 3-dioxygenase, and RANTES is a major immune effector in Mediterranean spotted fever rickettsiosis. J Infect Dis 2007;196:770-81.
39. Feng H-M, Popov VL, Yuoh G, Walker DH. Role of T lymphocyte subsets in immunity to spotted fever group rickettsiae. J Immunol 1997;158:5314-20.
40. Walker DH, Olano JP, Feng H-M. Critical role of cytotoxic T lymphocytes in immune clearance of rickettsial infection. Infect Immun 2001;69(3):1841-6.
41. Walker DH, Popov VL, Feng H-M. Establishment of a novel endothelial target mouse model of a typhus group rickettsiosis: evidence for critical roles for gamma interferon and CD8 T lymphocytes. Lab Invest 2000;80(9):1361-72.
42. Feng H-M, Walker DH. Cross-protection between distantly related spotted fever group rickettsiae. Vaccine 2003;21:3901-5.
43. Valbuena G, Jordan JM, Walker DH. T cells mediate cross-protective immunity between spotted fever group rickettsiae and typhus group rickettsiae. J Infect Dis 2004;190:1221-7.
44. McDonald GA, Anacker RL, Mann RE, Milch LJ. Protection of guinea pigs from experimental RockyMountain spotted fever with a cloned antigen of Rickettsia rickettsii. J Infect Dis 1988;158:228-31.
45. Sumner JW, Sims KG, Jones DC, Anderson BE. Protection of guineapigs from experimental Rocky Mountain spotted fever by immunization with baculovirus-expressed Rickettsia rickettsii rOmpA protein. Vaccine 1995;13:29-35.
46. Vishwanath S, McDonald GA, Watkins NG. A recombinant Rickettsia conorii vaccine protects guinea pigs from experimental boutonneuse fever and Rocky Mountain spotted fever. Infect Immun 1990;58:646-53.
47. Crocquet-Valdes P, Diaz-Montero CM, Feng H-M, Li H, Barrett ADT, Walker DH. Immunization with a portion of rickettsial outer membrane protein A stimulates protective immunity against spotted fever rickettsiosis. Vaccine 2002;20:979-88.
48. Diaz-Montero CM, Feng H-M, Crocquet-Valdes PA, Walker DH. Identification of protective components of two major outer membrane proteins of spotted fever group rickettsiae. Am J Trop Med Hyg 2001;65(4):371-8.
49. Bourgeois AL, Dasch GA. The species-specific surface protein antigen of Rickettsia typhi: immunogenicity and protective efficacy in guinea pigs. In: Burgdorfer W, Anacker RL, editors. Rickettsiae and rickettsial diseases. New York: Academic Press; 1981. p. 71-80.
50. Driskell LO, Yu XJ, Zhang L, Liu Y, Popov VL, Walker DH, et al. Directed mutagenesis of the Rickettsia prowazekii pld gene encoding phospholipase D. Infect Immun 2009;77(8):3244-8.